Management in the emergency room of patients requiring hospital treatment of community-acquired pneumonia

Revista Espanola de Quimioterapia

Volumn 22, Issue 1, 2009, Pages 4-9

  Martinez D ^a   Alvarez Rodriguez V ^b   Martinez Ortiz De Zarate M ^c   Rivas, M ^d   Gimenez M J ^e   Aguilar, L ^e   Ruiz Polaina, M J ^f   Barberan J ^g   Prieto, José ^e  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL DE MÓSTOLES   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e SCHOOL OF MEDICINE   (Spain)

^f HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^g HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

Author keywords

Community acquired pneumonia; Emergency room; Empirical treatment; Legionella urinary test; Pneumococcal urinary test

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BETA LACTAM ANTIBIOTIC; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DIABETES MELLITUS; EMERGENCY CARE; EMERGENCY WARD; FEMALE; HEART DISEASE; HOSPITAL CARE; HUMAN; HYPERTENSION; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; SPAIN; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; YOUNG ADULT;

EID: 68549099622     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, et al. The emergency department community-acquired pneumonia trial: Methodology of a quality improvement intervention. Ann Emerg Med 2004;43:770-782
2. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347-382
3. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134-141 (Pubitemid 26021681)
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250 (Pubitemid 27044625)
5. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997;157:1709-1718
6. Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 1990;142:369-373
7. Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000;15:757-763 (Pubitemid 30196306)
8. Monge V, San-Martín VM, González A. The burden of community-acquired pneumonia in Spain. Eur J Public Health 2001;11:362-364 (Pubitemid 33126476)
9. Fernández Sabe N, Gudiol F. Tratamiento de las infecciones de vías respiratorias bajas. In García-Rodríguez JA, García-Sánchez JE, Gobernado M, Picazo JJ, Prieto J (eds): Antimicrobianos en medicina, 2° ed. Barcelona: Proust Science and Sociedad Española de Quimioterapia, 2006, pp. 407-415
10. Calbo E, Ochoa de Echaguen A, Rodríguez-Carballeira M, Ferrer C, Garau J. Ingresos, estancia y mortalidad de las neumonías adquiridas en la comunidad en un hospital de agudos. Correlación entre el índice pronóstico de severidad y los criterios clínicos tradicionales de valoración de la gravedad. Enferm Infecc Microbiol Clin 2004;22:64-69
11. González-Moraleja J, Sesma P, González C, López ME, García JF, Álvarez-Sala JL. What is the cost of inappropriate admission of pneumonia patients? Arch Bronconeumol 1999;35:312-316
12. Moran G. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones. J Emerg Med 2006;30:377-387 (Pubitemid 43782790)
13. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995;50:543-547
14. th ed. Philadelphia: Elsevier Inc., 2005, pp. 819-845
15. Schouten JA, Hulscher ME, Kullberg BJ, Cox A, Gyssens IC, van der Meer JW, et al. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. J Antimicrob Chemother 2005;56:575-582 (Pubitemid 41264139)
16. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC, Metlay JP, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med 1998;158:1350-1356 (Pubitemid 28287529)
17. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C; Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-1433
18. Orero A, González J, Prieto J por el Grupo para el Estudio del Uso Racional de Antibióticos (URANO). Antibióticos en los hogares españoles. Implicaciones médicas y socioeconómicas. Med Clin (Barc) 1997;109:782-785
19. González J, Orero A, Prieto J por el Grupo para el Estudio del Uso Racional de Antibióticos (URANO). Almacenamiento de antibióticos en los hogares españoles. Rev Esp Quimioterap 2006;19:275-285
20. Bouza E, Rodríguez-Creixems M. ¿Son las quinolonas los fármacos de elección en la neumonía causada por microorganismos del género Legionella? Enferm Infecc Microbiol Clin 1999; 17 (Suppl. 1):19-23.
21. Sopena N, Sabria M, Pedro-Botet ML, Manterola JM, Matas L, Domínguez J, et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis 1999;18:852-858 (Pubitemid 30066162)
22. Yu VL, Greenberg RN, Zadeikis N, Stout JE, Khashab MM, Olson WH, et al. Levofloxacin efficacy in the treatment of community-acquired pneumonia. Chest 2004;125:2135-2139
23. Yu VL. Legionella pneumophila (Legionnaires' disease). In Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000, pp. 2424-2435
24. Kohler RB, Winn WC Jr, Wheat LJ. Onset and duration of urinary antigen excretion in legionnaires disease. J Clin Microbiol 1984;20:605-607
25. Fields BS, Benson RF, Besser RE. Legionella and legionnaires disease: 25 years of investigation. Clin Microbiol Rev 2002;15:506-526
26. Shah PB, Giudice JC, Griesback R Jr, Morley TF, Vasoya A. The newer guidelines for the management of community-acquired pneumonia. J Am Osteopath Assoc 2004;104:521-526 (Pubitemid 40543139)
27. Pérez-Trallero E, García-de-la-Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Re R, et al. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 2005;49:1965-1972 (Pubitemid 40631613)
28. Pérez-Trallero E, García-Rey C, Martín- Sánchez AM, Aguilar L, García-de-Lomas J, Ruiz J. Spanish Surveillance Group for Respiratory Pathogens (SAUCE Program). Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain. Antimicrob Agents Chemother 2002;46:2665-2667
29. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-1754 (Pubitemid 32578779)
30. Santos J, Aguilar L, García-Méndez E, Siquier B, Custardoy J, García-Rey C, et al. Clinical characteristics and response to newer quinolones in Legionella pneumonia: a report of 28 cases. J Chemother 2003;15:461-465
31. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000;160:1399-1408
32. Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080-2084
33. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-644 (Pubitemid 38392978)